A Rakuten Company

More titles to consider

Shopping Cart



This book bridges the gap between practitioners of supply-chainmanagement and pharmaceutical industry experts. It aims to helpboth these groups understand the different worlds they live in andhow to jointly contribute to meaningful improvements insupply-chains within the globally important pharmaceutical sector.Scientific and technical staff must work closely with supply-chainpractitioners and other relevant parties to help secure responsive,cost effective and risk mitigated supply chains to compete on aworld stage. This should not wait until a drug has been registered,but should start as early as possible in the development processand before registration or clinical trials. The author suggeststhat CMC (chemistry manufacturing controls) drug development mustreset the line of sight – from supply of drug to the clinicand gaining a registration, to the building of a patient valuestream. Capable processes and suppliers, streamlined logistics,flexible plant and equipment, shorter cycle times, effective flowof information and reduced waste. All these factors can and shouldbe addressed at the CMC development stage.

People who read this also enjoyed

Get a 1 year subscription
for / issue

Read This On

You can read this item using any of the following Kobo apps and devices:

  • IOS